We're sorry but the Program doesn't work properly without JavaScript enabled. Please enable it to continue.
Horizontal
Vertical
List
Program
Chairs & Speakers
Favourites
Download Program
Help
Event Times (GMT+1)
Local Times (GMT+2)
Login
Session Groups
Session Types
Networking
Data Blitz Session
Spotlight Session
Symposium
Meet the Experts / Campfire Session
Plenary
Break
Session
Industry
Posters
Featured Communication
Rooms
Back
Data Blitz Session
Session Room: M4
Monday, June 29, 02:50 PM – 04:05 PM
Data Blitz 12:
Depression 3
Chair:
Giovanni Martinotti (Chieti, Italy)
Chair:
Libor Ustohal (Brno, Czech Republic)
S-ketamine, but not R-ketamine, increases the spontaneous firing rate and the AMPA-evoked response of pyramidal neurons in the rat prefrontal cortex
Speaker:
Mostafa El Mansari (Ottawa, Canada)
02:50 PM – 02:56 PM
6 min
Intranasal administration of transforming growth factor beta 1 and its effect on the monoaminergic neurons in the rat brain
Speaker:
Matej Račický (Bratislava, Slovakia)
02:56 PM – 03:02 PM
6 min
Cardiovascular mortality and depression: a systematic review and meta-analysis of the association with antidepressant treatment and co-morbidity
Speaker:
Tiago da Silva Costa (Newcastle upon Tyne, United Kingdom)
03:02 PM – 03:08 PM
6 min
Resolution of inflammation in metabolic mood disorders
Speaker:
Aisan Akhgari (Aarhus, Denmark)
03:08 PM – 03:14 PM
6 min
Predicting remission outcomes after subthreshold prolonged intermittent theta-burst stimulation in pharmacoresistant depression
Speaker:
Chih-Ming Cheng (Taipei City, Taiwan)
03:14 PM – 03:20 PM
6 min
Detecting neuroplastic effects induced by ketamine and classic psychedelics in healthy human subjects
Speaker:
Claudio Agnorelli (London, United Kingdom)
03:20 PM – 03:26 PM
6 min
Placebo and sleep-related mechanisms in self-operable device-based depression treatment: a secondary analysis of a randomized sham-controlled trial of wearable transcranial photobiomodulation (tPBM)
Speaker:
Ta-Wei Guu (Yunlin, Taiwan)
03:26 PM – 03:32 PM
6 min
Magnetic seizure therapy for major depressive disorder: clinical efficacy, safety, and prefrontal activation measured by functional near-infrared spectroscopy
Speaker:
Ran Wang (Shijiazhuang, China)
03:32 PM – 03:38 PM
6 min
Association between CYP2D6 genotype and treatment outcomes in hospitalized patients with major depressive disorder: a retrospective cohort study
Speaker:
Aleksandra Jeremic (Belgrade, Serbia)
03:38 PM – 03:44 PM
6 min
Lithium and Quetiapine Augmentation Therapy in treatment-resistant depression with atypical features
Speaker:
Gianmarco Ingrosso (London, United Kingdom)
03:44 PM – 03:50 PM
6 min
Spectral TMS: a novel protocol for rapid antidepressant response
Speaker:
Andrew Leuchter (Los Angeles, United States)
03:50 PM – 03:56 PM
6 min
Moderated Discussion, Q&A
03:56 PM – 04:05 PM
9 min